+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical Significance of Serum Anti-Human Papillomavirus 16 and 18 Antibodies in Cervical Neoplasia



Clinical Significance of Serum Anti-Human Papillomavirus 16 and 18 Antibodies in Cervical Neoplasia



Obstetrics & Gynecology 121(2, Part 1): 321-329




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067591178

Download citation: RISBibTeXText

DOI: 10.1097/aog.0b013e31827c59f7


Related references

Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia. Obstetrics and Gynecology 121(2 Pt 1): 321-329, 2013

Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. American Journal Of Obstetrics & Gynecology. 174(3): 937-942, 1996

Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer. Cancer Medicine 7(11): 5655-5664, 2018

IgG antibodies to human papillomavirus type 16 and serum retinol may jointly protect against cervical neoplasia. Stanley, M A Immunology of human papillomaviruses 113-118, 1994

Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia. Viral Immunology 14(4): 415-424, 2002

Atypical squamous cells of undetermined significance, human papillomavirus, and cervical intraepithelial neoplasia 2 or 3 in adolescents: ASC-US, age, and high-grade cervical neoplasia. Journal of Lower Genital Tract Disease 10(3): 140-145, 2006

Neutralizing antibodies against human papillomavirus types 16, 18, 31, 52, and 58 in serum samples from women in Japan with low-grade cervical intraepithelial neoplasia. Clinical and Vaccine Immunology 15(10): 1536-1540, 2008

Clinical significance of human papillomavirus infection of the uterine cervix in the development of cervical intraepithelial neoplasia. British Journal of Venereal Diseases 60(3): 182-185, 1984

Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer. Cancer 74(8): 2307-2313, 1994

Clinical Significance of Serum Human Papillomavirus Dna in Cervical Carcinoma. Obstetrics & Gynecology 102(6): 1344-1351, 2003

Clinical significance of serum human papillomavirus DNA in cervical carcinoma. Obstetrics and Gynecology 102(6): 1344-1351, 2003

Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia. International Journal of Cancer 43(1): 36-40, 1989

Prevalence and histologic significance of cervical human papillomavirus DNA detected in women at low and high risk for cervical neoplasia. Obstetrics and Gynecology 86(4 Pt 1): 499-503, 1995

Prevalence of serum antibodies to LA-1 oncoprotein, herpes simplex virus type-2 glycoprotein and human papillomavirus type 16 transactivator (E2) protein among Indian women with cervical neoplasia. Indian Journal of Experimental Biology 36(10): 967-972, 1999

Antibodies to human papillomavirus type 16 in patients with cervical neoplasia. Lancet 335(8688): 551-552, 1990